Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Matrilin-2 expression distinguishes clinically relevant subsets of pilocytic astrocytoma.

Sharma MK, Watson MA, Lyman M, Perry A, Aldape KD, Deák F, Gutmann DH.

Neurology. 2006 Jan 10;66(1):127-30.

PMID:
16401863
2.

Paired overexpression of ErbB3 and Sox10 in pilocytic astrocytoma.

Addo-Yobo SO, Straessle J, Anwar A, Donson AM, Kleinschmidt-Demasters BK, Foreman NK.

J Neuropathol Exp Neurol. 2006 Aug;65(8):769-75.

PMID:
16896310
3.

Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.

Rorive S, Maris C, Debeir O, Sandras F, Vidaud M, Bièche I, Salmon I, Decaestecker C.

J Neuropathol Exp Neurol. 2006 Aug;65(8):794-807.

PMID:
16896313
4.

Expression of Rac3 in human brain tumors.

Hwang SL, Chang JH, Cheng TS, Sy WD, Lieu AS, Lin CL, Lee KS, Howng SL, Hong YR.

J Clin Neurosci. 2005 Jun;12(5):571-4.

PMID:
15993075
5.

Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypes.

Rodriguez FJ, Giannini C, Asmann YW, Sharma MK, Perry A, Tibbetts KM, Jenkins RB, Scheithauer BW, Anant S, Jenkins S, Eberhart CG, Sarkaria JN, Gutmann DH.

J Neuropathol Exp Neurol. 2008 Dec;67(12):1194-204. doi: 10.1097/NEN.0b013e31818fbe1e.

6.

Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.

Colin C, Baeza N, Bartoli C, Fina F, Eudes N, Nanni I, Martin PM, Ouafik L, Figarella-Branger D.

Oncogene. 2006 May 4;25(19):2818-26.

PMID:
16314830
7.

Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma.

Potter N, Karakoula A, Phipps KP, Harkness W, Hayward R, Thompson DN, Jacques TS, Harding B, Thomas DG, Palmer RW, Rees J, Darling J, Warr TJ.

Neoplasia. 2008 Aug;10(8):757-72.

8.

Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas.

Platten M, Giordano MJ, Dirven CM, Gutmann DH, Louis DN.

Am J Pathol. 1996 Aug;149(2):621-7.

9.

Comparative gene expression profile analysis of neurofibromatosis 1-associated and sporadic pilocytic astrocytomas.

Gutmann DH, Hedrick NM, Li J, Nagarajan R, Perry A, Watson MA.

Cancer Res. 2002 Apr 1;62(7):2085-91.

10.

Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature.

Tchoghandjian A, Fernandez C, Colin C, El Ayachi I, Voutsinos-Porche B, Fina F, Scavarda D, Piercecchi-Marti MD, Intagliata D, Ouafik L, Fraslon-Vanhulle C, Figarella-Branger D.

Brain. 2009 Jun;132(Pt 6):1523-35. doi: 10.1093/brain/awp048. Epub 2009 Mar 31.

PMID:
19336457
11.

MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2.

Ho CY, Bar E, Giannini C, Marchionni L, Karajannis MA, Zagzag D, Gutmann DH, Eberhart CG, Rodriguez FJ.

Neuro Oncol. 2013 Jan;15(1):69-82. doi: 10.1093/neuonc/nos269. Epub 2012 Nov 15.

12.

Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin.

Sharma MK, Mansur DB, Reifenberger G, Perry A, Leonard JR, Aldape KD, Albin MG, Emnett RJ, Loeser S, Watson MA, Nagarajan R, Gutmann DH.

Cancer Res. 2007 Feb 1;67(3):890-900.

13.

Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.

Gutmann DH, Donahoe J, Brown T, James CD, Perry A.

Neuropathol Appl Neurobiol. 2000 Aug;26(4):361-7.

PMID:
10931370
14.

Expression analyses of 27 DNA repair genes in astrocytoma by TaqMan low-density array.

Jiang Z, Hu J, Li X, Jiang Y, Zhou W, Lu D.

Neurosci Lett. 2006 Dec 1;409(2):112-7. Epub 2006 Oct 10.

PMID:
17034947
15.

Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis.

MacDonald TJ, Pollack IF, Okada H, Bhattacharya S, Lyons-Weiler J.

Methods Mol Biol. 2007;377:203-22. Review.

PMID:
17634619
16.

Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.

Yamano Y, Uzawa K, Shinozuka K, Fushimi K, Ishigami T, Nomura H, Ogawara K, Shiiba M, Yokoe H, Tanzawa H.

Int J Oncol. 2008 May;32(5):1001-9.

PMID:
18425326
17.

DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas.

Kunitz A, Wolter M, van den Boom J, Felsberg J, Tews B, Hahn M, Benner A, Sabel M, Lichter P, Reifenberger G, von Deimling A, Hartmann C.

Brain Pathol. 2007 Oct;17(4):363-70. Epub 2007 Jul 4.

PMID:
17610521
18.

ATAD 3A and ATAD 3B are distal 1p-located genes differentially expressed in human glioma cell lines and present in vitro anti-oncogenic and chemoresistant properties.

Hubstenberger A, Labourdette G, Baudier J, Rousseau D.

Exp Cell Res. 2008 Sep 10;314(15):2870-83. doi: 10.1016/j.yexcr.2008.06.017. Epub 2008 Jul 1.

PMID:
18639545
19.

High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas.

Deshmukh H, Yeh TH, Yu J, Sharma MK, Perry A, Leonard JR, Watson MA, Gutmann DH, Nagarajan R.

Oncogene. 2008 Aug 7;27(34):4745-51. doi: 10.1038/onc.2008.110. Epub 2008 Apr 14.

PMID:
18408760
20.

Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival.

Takei H, Yogeswaren ST, Wong KK, Mehta V, Chintagumpala M, Dauser RC, Lau CC, Adesina AM.

J Neurooncol. 2008 Jan;86(2):183-90. Epub 2007 Aug 10.

PMID:
17690840

Supplemental Content

Support Center